Site icon BPSA – Learner Portal

Learn about Yellow Card reporting with our new assessment

The Yellow Card scheme is the UK’s system for collecting and monitoring information about suspected side effects or safety concerns with medicines and medical devices. Run by the MHRA (Medicines and Healthcare products Regulatory Agency), it serves as a critical medicine surveillance tool.That’s exactly why we’ve developed a new training resource in partnership with the MHRA and the British Pharmacological Society (BPS).

When should you report?

Do you know what information to include? Whether your suspicion is strong enough to warrant a report? The MHRA recommends reporting every time on the basis of reasonable suspicion. You do not need to establish causation before submitting a report. A report should be made whenever you suspect a medicine may have caused an adverse reaction.

Building your knowledge with the new assessment

We’ve developed an MHRA Yellow Card scheme assessment specifically to help better understand the regulatory role of the MHRA, the importance of post-market surveillance activities in the real world and the value of reporting any suspected safety concerns to the Yellow Card scheme.

What the assessment covers:

The Assessment is a collaboration between BPS and the Medicines and Healthcare products Regulatory Agency (MHRA), and is delivered as a one-hour  formative assessment, containing two modules:

  1. Module 1: ‘MHRA and the Yellow Card scheme’ – general knowledge questions about the role of the MHRA and the Yellow Card scheme; and
  2. Module 2: ‘Reporting Adverse Incidents’ – scenario-based case studies about adverse incidents and reporting routes.

Why complete it now:

Learning about Yellow Card reporting during training means it becomes integrated into your practice from day one. When you encounter your first suspected adverse drug reaction, you’ll already know the appropriate steps. The process will be familiar rather than something you need to investigate while managing clinical responsibilities.

Pharmacovigilance also features in professional assessments, including the PSA. Understanding how to identify and report safety concerns is a core competency expected of newly qualified prescribers.

How it works:

The assessment is available on the portal and can be completed at a time that suits your schedule. You’ll work through interactive case based scenarios that mirror real clinical situations. Once completed, you’ll be ready to use the Yellow Card scheme throughout your career via the online portal at yellowcard.mhra.gov.uk or the Yellow Card app.

Ready to get started?

Access the MHRA Yellow Card scheme assessment through the portal’s eLearning section  https://portal.bpsassessment.com/product/yellow-card-scheme/ 

Explore more learning resources

The Yellow Card assessment is part of our comprehensive range of training materials designed to support your prescribing journey, more resources can be found here: https://portal.bpsassessment.com/ 

For more information about the Yellow Card scheme visit: 

https://yellowcard.mhra.gov.uk/ 

https://www.bps.ac.uk/education-engagement/society-training-opportunities/bps-assessment-training-solutions/mhra-yellow-card-scheme-assessment

Exit mobile version